Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Multimodality Imaging in Cranial Giant Cell Arteritis : First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. / Brittain, Jane Maestri; Hansen, Michael Stormly; Carlsen, Jonathan Frederik; Brandt, Andreas Hjelm; Terslev, Lene; Jensen, Mads Radmer; Lindberg, Ulrich; Larsson, Henrik Bo Wiberg; Heegaard, Steffen; Døhn, Uffe Møller; Klefter, Oliver Niels; Wiencke, Anne Katrine; Subhi, Yousif; Hamann, Steffen; Haddock, Bryan.

In: Diagnostics, Vol. 14, No. 1, 81, 2024.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Brittain, JM, Hansen, MS, Carlsen, JF, Brandt, AH, Terslev, L, Jensen, MR, Lindberg, U, Larsson, HBW, Heegaard, S, Døhn, UM, Klefter, ON, Wiencke, AK, Subhi, Y, Hamann, S & Haddock, B 2024, 'Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging', Diagnostics, vol. 14, no. 1, 81. https://doi.org/10.3390/diagnostics14010081

APA

Brittain, J. M., Hansen, M. S., Carlsen, J. F., Brandt, A. H., Terslev, L., Jensen, M. R., Lindberg, U., Larsson, H. B. W., Heegaard, S., Døhn, U. M., Klefter, O. N., Wiencke, A. K., Subhi, Y., Hamann, S., & Haddock, B. (2024). Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. Diagnostics, 14(1), [81]. https://doi.org/10.3390/diagnostics14010081

Vancouver

Brittain JM, Hansen MS, Carlsen JF, Brandt AH, Terslev L, Jensen MR et al. Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. Diagnostics. 2024;14(1). 81. https://doi.org/10.3390/diagnostics14010081

Author

Brittain, Jane Maestri ; Hansen, Michael Stormly ; Carlsen, Jonathan Frederik ; Brandt, Andreas Hjelm ; Terslev, Lene ; Jensen, Mads Radmer ; Lindberg, Ulrich ; Larsson, Henrik Bo Wiberg ; Heegaard, Steffen ; Døhn, Uffe Møller ; Klefter, Oliver Niels ; Wiencke, Anne Katrine ; Subhi, Yousif ; Hamann, Steffen ; Haddock, Bryan. / Multimodality Imaging in Cranial Giant Cell Arteritis : First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging. In: Diagnostics. 2024 ; Vol. 14, No. 1.

Bibtex

@article{fd210b86d9be4618b3975fe3188dec73,
title = "Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging",
abstract = "In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.",
keywords = "3D black blood, FDG PET/CT, giant cell arteritis, MRI, multimodality imaging, non-contrast enhancement, temporal artery biopsy, vascular ultrasound",
author = "Brittain, {Jane Maestri} and Hansen, {Michael Stormly} and Carlsen, {Jonathan Frederik} and Brandt, {Andreas Hjelm} and Lene Terslev and Jensen, {Mads Radmer} and Ulrich Lindberg and Larsson, {Henrik Bo Wiberg} and Steffen Heegaard and D{\o}hn, {Uffe M{\o}ller} and Klefter, {Oliver Niels} and Wiencke, {Anne Katrine} and Yousif Subhi and Steffen Hamann and Bryan Haddock",
note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2024",
doi = "10.3390/diagnostics14010081",
language = "English",
volume = "14",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI AG",
number = "1",

}

RIS

TY - JOUR

T1 - Multimodality Imaging in Cranial Giant Cell Arteritis

T2 - First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging

AU - Brittain, Jane Maestri

AU - Hansen, Michael Stormly

AU - Carlsen, Jonathan Frederik

AU - Brandt, Andreas Hjelm

AU - Terslev, Lene

AU - Jensen, Mads Radmer

AU - Lindberg, Ulrich

AU - Larsson, Henrik Bo Wiberg

AU - Heegaard, Steffen

AU - Døhn, Uffe Møller

AU - Klefter, Oliver Niels

AU - Wiencke, Anne Katrine

AU - Subhi, Yousif

AU - Hamann, Steffen

AU - Haddock, Bryan

N1 - Publisher Copyright: © 2023 by the authors.

PY - 2024

Y1 - 2024

N2 - In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.

AB - In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.

KW - 3D black blood

KW - FDG PET/CT

KW - giant cell arteritis

KW - MRI

KW - multimodality imaging

KW - non-contrast enhancement

KW - temporal artery biopsy

KW - vascular ultrasound

U2 - 10.3390/diagnostics14010081

DO - 10.3390/diagnostics14010081

M3 - Journal article

C2 - 38201390

AN - SCOPUS:85181923981

VL - 14

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 1

M1 - 81

ER -

ID: 379712158